- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanomix, Inc., a leading nanoelectronic detection company commercializing high-value medical diagnostic and monitoring applications, today announced that President and CEO, David Macdonald, will present a corporate overview on Monday, September 24, 2007 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) during the UBS Global Life Sciences Conference. The conference is taking place at the Grand Hyatt New York in New York City. During his presentation, Mr. Macdonald will provide an overview of the Company's pipeline and Sensation(TM) detection platform. A breakout session for discussion will follow.
About Nanomix, Inc.
Nanomix is a leading nanoelectronic detection company launching detection devices based on Sensation(TM) technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across high value respiratory and biomarker detection applications where low power consumption, small size, and ultra-sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California.
For more information, please click here
Vice President of Sales, Marketing and Business Development
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
New remote-controlled microrobots for medical operations July 23rd, 2016
New probe developed for improved high resolution measurement of brain temperature: Improved accuracy could allow researchers to measure brain temperature in times of trauma when small deviations in temperature can lead to additional brain injury July 23rd, 2016
Nanometrics Announces Upcoming Investor Events July 20th, 2016